• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.05% Nasdaq Up 0.17%

    Immune Pharmaceuticals, Inc. (IMNP)

    -NasdaqCM
    0.17 Up 0.00(1.10%) Feb 24, 4:00PM EST
    Prev Close:0.17
    Open:0.17
    Bid:0.16 x 6000
    Ask:0.20 x 5000
    1y Target Est:3.00
    Beta:2.5437
    Next Earnings Date:N/A
    Day's Range:0.17 - 0.18
    52wk Range:0.16 - 0.64
    Volume:2,729,838
    Avg Vol (3m):5,988,120
    Market Cap:30.24M
    P/E (ttm):N/A
    EPS (ttm):-0.68
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMNP

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :N/A
    Quarterly EPS Est (Dec-16) :N/A
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Immune Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops and commercializes novel targeted therapeutics in the immuno-inflammation and immuno-oncology areas. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback